• James O'Connell, Cora McNally, Debbi Stanistreet, Eoghan de Barra, and Samuel J McConkey.
• Department of International Health and Tropical Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland. jamesoconnell@rcsi.com.
• Ir J Med Sci. 2023 Aug 1; 192 (4): 154715531547-1553.

BackgroundEnding tuberculosis (TB) is a global priority and targets for doing so are outlined in the World Health Organization (WHO) End TB Strategy. For low-incidence countries, eliminating TB requires high levels of wealth, low levels of income inequality and effective TB programmes and services that can meet the needs of people who have not benefited from these and are still at risk of TB. In Ireland, numerous reports have noted a need for more funding for TB prevention and control.AimThe aim of this research was to estimate the cost of not meeting the WHO End TB target of a 90% reduction in TB incidence in Ireland between 2015 and 2035.MethodsThe cost of projected TB cases between 2022 and 2035 is estimated based on trends in surveillance data for the period 2015 to 2019 and outcomes reported in the literature.ResultsBetween 2022 and 2035, it is projected that a failure to meet the WHO End TB Strategy target will result in an additional 989 cases of TB, 577.3 disability-adjusted life years and 35 deaths with TB in Ireland. The cost of this is estimated to be €70.779 million.ConclusionGiven the estimated cost, Ireland's current prospects of eliminating TB and the tendency towards programmatic funding internationally, greater investment in TB prevention and control in Ireland is justifiable. A national elimination strategy with actions at the levels of the social determinants of health, the health system and the TB programme should be funded.© 2022. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.

13 keywords...

hide…